share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

SEC announcement ·  Mar 27 18:25
Summary by Moomoo AI
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more